Allogeneic hematopoietic stem cell transplantation for primary central nervous system lymphoma.
作者信息
Mika Thomas, Ladigan Swetlana, Baraniskin Alexander, Vangala Deepak, Seidel Sabine, Hopfer Olaf, Kiehl Michael, Schroers Roland
机构信息
Department of Hematology and Oncology, Universitätsklinikum Knappschaftskrankenhaus Bochum.
Department of Neurology, Universitätsklinikum Knappschaftskrankenhaus Bochum.
出版信息
Haematologica. 2020 Apr;105(4):e160-e163. doi: 10.3324/haematol.2019.227199. Epub 2019 Aug 8.
Abstract
摘要
相似文献
1
Allogeneic hematopoietic stem cell transplantation for primary central nervous system lymphoma.异基因造血干细胞移植治疗原发性中枢神经系统淋巴瘤。
Haematologica. 2020 Apr;105(4):e160-e163. doi: 10.3324/haematol.2019.227199. Epub 2019 Aug 8.
2
Hematopoietic stem cell transplantation in primary central nervous system lymphoma: a review of the literature.原发性中枢神经系统淋巴瘤的造血干细胞移植：文献综述
Int J Hematol. 2019 Mar;109(3):260-277. doi: 10.1007/s12185-019-02594-1. Epub 2019 Jan 22.
3
Outcomes of allogeneic hematopoietic stem cell transplantation in secondary central nervous system lymphoma: a case series.异基因造血干细胞移植治疗继发性中枢神经系统淋巴瘤的疗效：病例系列报道
Leuk Lymphoma. 2023 Feb;64(2):507-510. doi: 10.1080/10428194.2022.2151839. Epub 2023 Jan 17.
4
A Tale of Two Eras: The Story of Autologous Stem Cell Transplantation with and without Thiotepa for Primary Central Nervous System Lymphoma.两个时代的故事：原发性中枢神经系统淋巴瘤自体干细胞移植联合与不联合噻替派的故事
Biol Blood Marrow Transplant. 2019 May;25(5):e141-e142. doi: 10.1016/j.bbmt.2019.03.014. Epub 2019 Mar 14.
5
[High-dose methotrexate plus hematopoietic stem cell transplantation supplemented by rituximab intrathecal injection for primary central nervous system lymphoma:two cases report and literature review].[大剂量甲氨蝶呤联合造血干细胞移植并鞘内注射利妥昔单抗治疗原发性中枢神经系统淋巴瘤：两例报告及文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2013 Feb;34(2):162-3.
6
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.非霍奇金淋巴瘤累及中枢神经系统患者的造血细胞移植大剂量疗法。
Biol Blood Marrow Transplant. 2000;6(3A):352-8. doi: 10.1016/s1083-8791(00)70060-7.
7
Transplantation for lymphoma: good for the brain as well as the body?淋巴瘤移植：对大脑和身体都有益？
Biol Blood Marrow Transplant. 2012 Jan;18(1):1-2. doi: 10.1016/j.bbmt.2011.11.006. Epub 2011 Nov 9.
8
Treatment of primary CNS lymphoma.原发性中枢神经系统淋巴瘤的治疗。
Blood. 2015 Feb 26;125(9):1360-1. doi: 10.1182/blood-2015-01-622498.
9
High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: Data From the Japan Society for Hematopoietic Cell Transplantation Registry.原发性中枢神经系统淋巴瘤的大剂量化疗联合自体造血干细胞移植：来自日本造血细胞移植学会登记处的数据。
Biol Blood Marrow Transplant. 2019 May;25(5):899-905. doi: 10.1016/j.bbmt.2019.01.020. Epub 2019 Jan 18.
10
Primary Central Nervous System Lymphoma-PART 2: Modern Therapeutic Management and Future Directions.原发性中枢神经系统淋巴瘤——第二部分：现代治疗管理与未来方向
Oncology (Williston Park). 2018 Feb 15;32(2):e11-e19.
引用本文的文献
1
Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition.嵌合抗原受体T细胞疗法治疗原发性或继发性中枢神经系统淋巴瘤患者的疗效和安全性：一项代表欧洲血液与骨髓移植协会（EBMT）和GoCART联盟开展的研究
Hemasphere. 2025 May 21;9(5):e70146. doi: 10.1002/hem3.70146. eCollection 2025 May.
2
Systemic Relapse in a Young Adult Patient with Primary CNS Diffuse Large B-Cell Lymphoma.一名原发性中枢神经系统弥漫性大B细胞淋巴瘤年轻成年患者的系统性复发
Case Rep Hematol. 2022 Jun 21;2022:7139661. doi: 10.1155/2022/7139661. eCollection 2022.
3
High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity.高剂量化疗联合自体造血干细胞移植治疗复发或难治性原发性中枢神经系统淋巴瘤：长期疗效、预后因素及毒性的回顾性单中心分析
Cancers (Basel). 2022 Apr 23;14(9):2100. doi: 10.3390/cancers14092100.
4
Treatment of leptomeningeal disease in blastic plasmacytoid dendritic cell neoplasm following tagraxofusp-erzs induction.在使用tagraxofusp-erzs诱导后治疗母细胞性浆细胞样树突状细胞瘤的软脑膜疾病。
Haematologica. 2022 Aug 1;107(8):2004-2007. doi: 10.3324/haematol.2022.280843.
5
Relapsed and refractory primary CNS lymphoma: treatment approaches in routine practice.复发难治性原发性中枢神经系统淋巴瘤：常规治疗方法
Ann Lymphoma. 2021 Sep;5:23. doi: 10.21037/aol-21-20.
6
Emerging Landscape of Immunotherapy for Primary Central Nervous System Lymphoma.原发性中枢神经系统淋巴瘤免疫治疗的新进展
Cancers (Basel). 2021 Oct 10;13(20):5061. doi: 10.3390/cancers13205061.
7
Systemic Approach to Recurrent Primary CNS Lymphoma: Perspective on Current and Emerging Treatment Strategies.复发性原发性中枢神经系统淋巴瘤的系统治疗方法：当前及新兴治疗策略的观点
Onco Targets Ther. 2020 Aug 20;13:8323-8335. doi: 10.2147/OTT.S192379. eCollection 2020.
本文引用的文献
1
Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma.噻替哌、白消安和环磷酰胺或白消安、环磷酰胺和依托泊苷大剂量化疗，随后进行自体干细胞移植以巩固原发性中枢神经系统淋巴瘤。
Ann Hematol. 2019 Jul;98(7):1657-1664. doi: 10.1007/s00277-019-03667-1. Epub 2019 Apr 15.
2
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study.原发中枢神经系统淋巴瘤患者年龄 60 岁及以下时采用放疗或自体造血干细胞移植治疗的结果：ANOCEF-GOELAMS 多中心随机Ⅱ期 PRECIS 研究结果。
J Clin Oncol. 2019 Apr 1;37(10):823-833. doi: 10.1200/JCO.18.00306. Epub 2019 Feb 20.
3
Treatment of Primary Central Nervous System Lymphoma: From Chemotherapy to Small Molecules.原发性中枢神经系统淋巴瘤的治疗：从化疗到小分子药物
Am Soc Clin Oncol Educ Book. 2018 May 23;38:604-615. doi: 10.1200/EDBK_200829.
4
[F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [F]FDG in human xenograft models.氟达拉滨-PET 作为区分中枢神经系统淋巴瘤和胶质母细胞瘤的有前途的工具：与 [F]FDG 在人异种移植模型中的比较分析。
Theranostics. 2018 Aug 10;8(16):4563-4573. doi: 10.7150/thno.26754. eCollection 2018.
5
Novel agents for primary central nervous system lymphoma: evidence and perspectives.原发性中枢神经系统淋巴瘤的新型药物治疗：现状与展望。
Blood. 2018 Aug 16;132(7):681-688. doi: 10.1182/blood-2018-01-791558. Epub 2018 Jul 9.
6
Donor cell chimerism evaluation in cerebrospinal fluid by short tandem repeat analysis following allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后通过短串联重复序列分析评估脑脊液中的供体细胞嵌合率。
Hum Immunol. 2018 Jul;79(7):537-538. doi: 10.1016/j.humimm.2018.04.001. Epub 2018 Apr 11.
7
Allogeneic stem cell transplantation for relapsed primary central nervous system lymphoma: Is it feasible?异基因干细胞移植治疗复发性原发性中枢神经系统淋巴瘤：可行吗？
Hematol Oncol Stem Cell Ther. 2019 Dec;12(4):220-225. doi: 10.1016/j.hemonc.2018.02.001. Epub 2018 Mar 16.
8
High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group.大剂量化疗联合自体造血干细胞支持治疗复发或难治性原发性中枢神经系统淋巴瘤：德国合作 PCNSL 研究组的前瞻性多中心试验。
Leukemia. 2017 Dec;31(12):2623-2629. doi: 10.1038/leu.2017.170. Epub 2017 May 31.
9
High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.硫替派、白消安和环磷酰胺大剂量化疗及自体干细胞移植用于初治完全缓解的原发性中枢神经系统淋巴瘤患者。
Cancer. 2017 Aug 15;123(16):3073-3079. doi: 10.1002/cncr.30695. Epub 2017 Apr 3.
10
PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma.纳武单抗进行程序性死亡受体1阻断治疗复发/难治性原发性中枢神经系统淋巴瘤和睾丸淋巴瘤。
Blood. 2017 Jun 8;129(23):3071-3073. doi: 10.1182/blood-2017-01-764209. Epub 2017 Mar 29.
Zotero 插件